Today: 10 April 2026
Browse Category

NYSE:JNJ 15 January 2026 - 23 January 2026

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson closed up 0.3% at $218.49 Thursday after reporting Q4 revenue of $24.56 billion and adjusted earnings of $2.46 per share. The company projected 2026 sales above estimates but faces ongoing pressure from U.S. drug pricing, tariffs, and talc litigation. A court-appointed special master recommended allowing expert testimony in the New Jersey talc case. J&J plans to appeal.
Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson shares rose 1.1% to $220.36 Thursday after the company posted fourth-quarter sales of $24.564 billion and adjusted EPS of $2.46, beating forecasts. J&J projected 2026 adjusted EPS of $11.43–$11.63 and sales up to $101 billion. The company warned of a $500 million tariff hit and ongoing legal risks from talc lawsuits. Investors reacted to declining Stelara sales and competition in medical devices.
22 January 2026
Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson shares slipped 0.05% to $218.01 in after-hours trading Wednesday after the company projected 2026 sales and profits above Wall Street estimates. Investors weighed the upbeat forecast against renewed legal risks as a court-appointed special master recommended allowing expert testimony in federal talc litigation involving over 67,500 lawsuits. J&J plans to appeal the ruling.
Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Johnson & Johnson shares fell 1.3% to $215.31 after its 2026 outlook and Q4 results, as renewed legal risks and pricing pressures weighed on investors. The company reported Q4 sales of $24.564 billion and forecasted 2026 adjusted EPS of $11.43–$11.63. Legal pressure increased after a special master advised allowing expert testimony in talc cancer lawsuits. Tariff risks and Stelara's decline added to market concerns.
21 January 2026
Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson shares slipped 0.2% to $218.21 in after-hours trading Tuesday ahead of quarterly earnings due Wednesday. The move followed a broad market selloff, with the Dow down 1.76% and the S&P 500 off 2.06% after new U.S. tariff threats. Analysts expect Q4 profit of $2.47 per share. The company faces ongoing litigation, including a $1.5 billion verdict over talc products.
Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

The Dow closed down 0.2% at 49,359.33 on Friday ahead of the MLK Day market holiday. Dow futures fell 0.7% after President Trump threatened a 10% tariff on imports from eight European nations tied to Greenland, with the rate set to rise to 25% in June if talks fail. European leaders condemned the move and gold hit new highs as investors sought safety. Traders await key earnings and Thursday’s PCE inflation data.
Trump’s Greenland tariff threat sets up a tense week for global stocks

Trump’s Greenland tariff threat sets up a tense week for global stocks

President Donald Trump threatened 10% tariffs on eight European countries tied to Greenland, escalating to 25% by June if no deal is reached. The S&P 500 closed nearly flat at 6,940.01, while the Dow and Nasdaq also posted slight losses. Europe’s STOXX 600 ended flat, and China’s regulator announced tighter market controls. U.S. markets will close Monday for Martin Luther King Jr. Day.
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

The U.S. Supreme Court will hear arguments Wednesday on President Trump’s effort to remove Fed Governor Lisa Cook. Stocks ended the week lower, with the S&P 500 at 6,940.01 and Brent crude at $64.13. China releases GDP data as Davos opens, while Japan nears a possible snap election. Prime Minister Takaichi may suspend Japan’s 8% food sales tax, risking a 5 trillion yen revenue hit.
Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson shares closed down 0.41% at $218.66 Friday and were flat after hours. The company reports fourth-quarter earnings January 21, with investors watching for updates on drug approvals and MedTech growth. FDA fast-track reviews and consumer-health deals remain in focus. Kenvue, spun off from J&J, faces a key shareholder vote January 29 on its sale to Kimberly-Clark.
Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson shares rose 2.3% to $218.55 in after-hours trading Wednesday after reporting its Tecvayli drug cut the risk of disease progression or death by 71% in a late-stage multiple myeloma trial. An independent committee recommended unblinding the study. Full results will be presented at an upcoming medical meeting. Investors await the company’s quarterly results next week.
1 2 3 4 5 8

Stock Market Today

  • U.S. Stocks Rally as Middle East Ceasefire Talks Boost Market Sentiment
    April 9, 2026, 7:38 PM EDT. U.S. stocks continued a strong run with the S&P 500 and Nasdaq extending their winning streaks to seven sessions, buoyed by optimism around ceasefire talks in the Middle East. The Philadelphia Semiconductor Index hit a record high, supported by gains from Amazon, Intel, Nike, and Brown-Forman. Oil prices rose modestly, settling near $98 a barrel amid tight supply concerns and restrictions on the Strait of Hormuz, a key oil shipping route. Bitcoin broke above $72,000, reflecting broader risk appetite. Market attention remains fixed on whether the ceasefire and direct Israel-Lebanon negotiations can be sustained, with U.S. Treasury yields largely unchanged. Analysts caution the S&P 500's 6,800 level is pivotal, noting sentiment balances positive headlines with skepticism. The memory sector's rally continues, and options data signals key technical support levels for market stability.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Go toTop